dear Juliette,
it was very nice to meet you. thank you for all your recommendations.
we will foresee your ideas.
-----Original Message-----
From: "Morgan, Juliette (CDC/CGH/DGHP)"
To: "nmamaladze@moh.gov.ge"
Date: Mon, 23 Mar 2015 10:03:09 +0000
Subject: very nice to meet you
> Dear Nino,
> It was very nice to meet with you today.
>
> Please see the communication "highlights" for this workshop that I
> shared with you already. This are just C, just things CDC would
> like to see mentioned but please feel free to change as you see
> necessary.
>
> Juliette
>
>
>
> * Purpose of workshop: Bring together national stakeholders
and
> international partners to discuss the timeline and details for Phase
1
> of Georgia's HCV elimination program.
>
> * Timeline for HCV elimination: HCV elimination will be a
> process that will span a number of years.
>
> * What is the Goal of the HCV elimination program: reduce
the
> morbidity and mortality caused by Hep C in Georgia, while also
> interrupting transmission of this infection and in that way
eventually
> eliminate it from the Georgian population. This is possible with the
> advent of treatments that are highly effective at curing chronically
> infected individuals of Hepatitis C (treatment as prevention) but
also
> other measures of prevention are necessary. The elimination plan
> therefore will include not only treatment for all the estimated
> 150,000 Georgians infected with HCV, but also efforts dedicated to
the
> prevention of new infections through education, policy, and
regulation.
> Treatment availability will occur in phases, and will be dispensed
to
> patients depending on severity of their disease.
>
> * How Phase 1 is defined: Hepatitis C is a disease that
> progresses slowly over years, so Georgians who are infected are at
all
> different stages of disease. Phase 1 of the elimination plan will
> target Georgians in later stages of disease who are in the greatest
> need of immediate treatment. Once those who are sickest have been
> treated, Georgia will move on to phase 2 of the elimination plan a)
to
> treat people who are in earlier stages of disease and b) to offer
> screening to those who think they may be at risk for HCV infection
but
> do not yet know their status.
>
> * Outcomes of March 26 ,27 workshop: Finalize the Phase 1
> implementation plan, defining the treatment centers, and providers
that
> will be involved in delivering care and treatment in phase 1;
> clarifying patient identification algorithms to determine who will
be
> eligible for immediate treatment in phase 1;; develop a registration
> process for Georgians who would like to be treated; prepare for the
> introduction of HCV drugs; review training sessions to ensure that
> providers have standard operating procedures for patient registry,
> treatment, and monitoring; finalize preparations for a national
> seroprevalence survey
>
> * Purpose and timeline of the serosurvey: Beginning in May,
> teams of public health professionals will randomly select households
in
> Georgia to participate in a national survey to estimate how many
people
> in Georgia are infected with hepatitis C. Teams will travel to
selected
> households between May and July of this year. For those who choose
to
> participate, the teams will take a small blood sample and ask
questions
> related to their health and possible exposure to HCV, and will
provide
> their test results free of charge. We encourage you to participate
in
> this important project, since it will help us begin the process of
HCV
> elimination in Georgia.
>
>
> Dr. Juliette Morgan
> Medical Epidemiologist, CAPT US PHS
> CDC Country Director
> South Caucasus CDC Office
> Phone: +(995 32) 224 46 57
> Fax: +(995 32) 224 46 59
> Mobile: +(995) 599 577 743
>
> NCDC, #9 M Asatiani Str.
> Tbilisi, 0186, Georgia
> Email: jtm7@cdc.gov
>